Inhibition of Reactive Oxygen Species Limits Expansion of Chronic Lymphocytic Leukemia Cells

Overview

Journal Leukemia

Specialties Hematology
Oncology

Date 2017 Jul 29

PMID 28751772

Citations 4

Authors

B Yigit

N Wang

S-S Chen

N Chiorazzi

C Terhorst

Affiliations

Soon will be listed here.

Citing Articles

Significance of PPARA as a Treatment Target for Chronic Lymphocytic Leukemia.

Xiang X, Li F, Zhou S, Zeng Y, Deng X, Zhang H PPAR Res. 2023; 2023:8456833.

PMID: 37404899 PMC: 10317583. DOI: 10.1155/2023/8456833.

1,5-Anhydroglucitol promotes pre-B acute lymphocytic leukemia progression by driving glycolysis and reactive oxygen species formation.

Zhu H, Ma H, Dong N, Wu M, Li D, Liu L BMC Cancer. 2023; 23(1):122.

PMID: 36747147 PMC: 9903573. DOI: 10.1186/s12885-023-10589-9.

Cell toxicity mechanism and biomarker.

Zhang Y Clin Transl Med. 2018; 7(1):34.

PMID: 30374795 PMC: 6206310. DOI: 10.1186/s40169-018-0212-7.

SLAMF6 in health and disease: Implications for therapeutic targeting.

Yigit B, Wang N, Herzog R, Terhorst C Clin Immunol. 2018; 204:3-13.

PMID: 30366106 PMC: 8969216. DOI: 10.1016/j.clim.2018.10.013.

References

Reth M . Hydrogen peroxide as second messenger in lymphocyte activation. Nat Immunol. 2002; 3(12):1129-34. DOI: 10.1038/ni1202-1129. View

Chen S, Batliwalla F, Holodick N, Yan X, Yancopoulos S, Croce C . Autoantigen can promote progression to a more aggressive TCL1 leukemia by selecting variants with enhanced B-cell receptor signaling. Proc Natl Acad Sci U S A. 2013; 110(16):E1500-7. PMC: 3631671. DOI: 10.1073/pnas.1300616110. View

Raza M, Siraj S, Arshad A, Waheed U, Aldakheel F, Alduraywish S . ROS-modulated therapeutic approaches in cancer treatment. J Cancer Res Clin Oncol. 2017; 143(9):1789-1809. DOI: 10.1007/s00432-017-2464-9. View

Rothstein T . Cutting edge commentary: two B-1 or not to be one. J Immunol. 2002; 168(9):4257-61. DOI: 10.4049/jimmunol.168.9.4257. View

Hamaguchi Y, Uchida J, Cain D, Venturi G, Poe J, Haas K . The peritoneal cavity provides a protective niche for B1 and conventional B lymphocytes during anti-CD20 immunotherapy in mice. J Immunol. 2005; 174(7):4389-99. DOI: 10.4049/jimmunol.174.7.4389. View

Yigit B, Halibozek P, Chen S, OKeeffe M, Arnason J, Avigan D . A combination of an anti-SLAMF6 antibody and ibrutinib efficiently abrogates expansion of chronic lymphocytic leukemia cells. Oncotarget. 2016; 7(18):26346-60. PMC: 5041984. DOI: 10.18632/oncotarget.8378. View

Hayakawa K, Formica A, Colombo M, Ichikawa D, Shinton S, Brill-Dashoff J . B cells generated by B-1 development can progress to chronic lymphocytic leukemia. Ann N Y Acad Sci. 2015; 1362:250-5. DOI: 10.1111/nyas.12768. View

Herman S, Niemann C, Farooqui M, Jones J, Mustafa R, Lipsky A . Ibrutinib-induced lymphocytosis in patients with chronic lymphocytic leukemia: correlative analyses from a phase II study. Leukemia. 2014; 28(11):2188-96. PMC: 4185271. DOI: 10.1038/leu.2014.122. View

Baniasadi S, Eftekhari P, Tabarsi P, Fahimi F, Raoufy M, Masjedi M . Protective effect of N-acetylcysteine on antituberculosis drug-induced hepatotoxicity. Eur J Gastroenterol Hepatol. 2010; 22(10):1235-8. DOI: 10.1097/MEG.0b013e32833aa11b. View

10.

Jitschin R, Hofmann A, Bruns H, Giessl A, Bricks J, Berger J . Mitochondrial metabolism contributes to oxidative stress and reveals therapeutic targets in chronic lymphocytic leukemia. Blood. 2014; 123(17):2663-72. DOI: 10.1182/blood-2013-10-532200. View

11.

Zhou Y, Hileman E, Plunkett W, Keating M, Huang P . Free radical stress in chronic lymphocytic leukemia cells and its role in cellular sensitivity to ROS-generating anticancer agents. Blood. 2003; 101(10):4098-104. DOI: 10.1182/blood-2002-08-2512. View

12.

Coutre S, Barrientos J, Brown J, de Vos S, Furman R, Keating M . Management of adverse events associated with idelalisib treatment: expert panel opinion. Leuk Lymphoma. 2015; 56(10):2779-86. PMC: 4732460. DOI: 10.3109/10428194.2015.1022770. View

13.

Iacovelli S, Hug E, Bennardo S, Duehren-von Minden M, Gobessi S, Rinaldi A . Two types of BCR interactions are positively selected during leukemia development in the Eμ-TCL1 transgenic mouse model of CLL. Blood. 2015; 125(10):1578-88. PMC: 4351506. DOI: 10.1182/blood-2014-07-587790. View

14.

Zhang W, Trachootham D, Liu J, Chen G, Pelicano H, Garcia-Prieto C . Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia. Nat Cell Biol. 2012; 14(3):276-86. PMC: 3290742. DOI: 10.1038/ncb2432. View

15.

Holmstrom K, Finkel T . Cellular mechanisms and physiological consequences of redox-dependent signalling. Nat Rev Mol Cell Biol. 2014; 15(6):411-21. DOI: 10.1038/nrm3801. View